Tin tức & Cập nhật

Real-world data reflect promising efficacy, safety of ozanimod for UC

30 Jan 2022 bởi

The first-in-class sphingosine-1-phosphate receptor modulator ozanimod showed promising efficacy and safety in a relatively treatment-refractory cohort of patients with ulcerative colitis (UC), according to the initial results of a prospective, observational cohort study presented at the Crohn’s and Colitis Congress 2022.

Real-world data reflect promising efficacy, safety of ozanimod for UC

30 Jan 2022

Pregnant women with type 1 diabetes likely to have gut inflammation

29 Jan 2022

Women with type 1 diabetes present with a shift in the gut mycobiome across pregnancy, and this shift is strongly linked to gut inflammation and impaired intestinal barrier function, as reported in a study.

Pregnant women with type 1 diabetes likely to have gut inflammation

29 Jan 2022

Could bariatric surgery prevent severe COVID-19?

28 Jan 2022 bởi

Individuals who have undergone bariatric surgery to treat obesity may have a reduced risk of developing severe COVID-19, according to a recent study.

Could bariatric surgery prevent severe COVID-19?

28 Jan 2022

Low FODMAP diet promising in management of persistent symptoms in coeliac disease

27 Jan 2022

For treated patients with coeliac disease (CD) who are experiencing persistent symptoms, a short-term diet with moderately low fermentable oligo-, di-, monosaccharides and polyols (FODMAP) helps reduce gastrointestinal symptoms and improve CD-specific health, as suggested in a study.

Low FODMAP diet promising in management of persistent symptoms in coeliac disease

27 Jan 2022

Mirikizumab improves disease, symptom severity in patients with Crohn’s disease

26 Jan 2022 bởi

Treatment with the anti-interleukin-23p19 inhibitor mirikizumab led to significant improvements in patient-assessed disease severity and activity, as well as abdominal pain, in individuals with moderate-to-severe active Crohn’s disease, according to phase II data presented at the Crohn’s and Colitis Congress (CCC) 2022.

Mirikizumab improves disease, symptom severity in patients with Crohn’s disease

26 Jan 2022

Investigative drug for ulcerative colitis passes muster in early trial

25 Jan 2022

The orally administered, small molecule, gut-targeted stabiliser of hypoxia-inducible factor-1α (HIF-1α) GB004 appears to improve disease activity in patients with ulcerative colitis, with the drug being well-tolerated, according to the results of a phase Ib trial.

Investigative drug for ulcerative colitis passes muster in early trial

25 Jan 2022

Consider AZA discontinuation in kids with sustained, deep remission of Crohn’s disease

22 Jan 2022

In children with Crohn’s disease with sustained clinical and deep remission, cessation of azathioprine (AZA) does not seem to lead to an excess risk of relapse, a recent study has found. In contrast, discontinuation of infliximab does entail such a risk.

Consider AZA discontinuation in kids with sustained, deep remission of Crohn’s disease

22 Jan 2022

Resection, haemodialysis in colon cancer patients tied to higher postoperative complication risk

20 Jan 2022

In colon cancer patients receiving curative surgery, undergoing haemodialysis still carries a high risk of postoperative complications despite advancements in perioperative management, a recent study has found.

Resection, haemodialysis in colon cancer patients tied to higher postoperative complication risk

20 Jan 2022

Nasal feeding tubes tied to fewer adverse events than feeding via ostomy

14 Jan 2022

Surgical feeding ostomies (eg gastrostomy) result in significantly higher in-hospital adverse event rates than natural orifice (eg, nasogastric or orogastric) feeding tubes, a study has shown. Thus, policies that require surgical feeding ostomies must be re-evaluated.

Nasal feeding tubes tied to fewer adverse events than feeding via ostomy

14 Jan 2022

Inpatient, ED use of faecal immunochemical testing mostly incorrect: study

14 Jan 2022

A recent study has discovered inappropriate use of faecal immunochemical testing (FIT) in emergency and inpatient settings. Moreover, FIT has led to more gastroenterology consultations but is not independently associated with inpatient endoscopy.

Inpatient, ED use of faecal immunochemical testing mostly incorrect: study

14 Jan 2022

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Real-world data reflect promising efficacy, safety of ozanimod for UC

Real-world data reflect promising efficacy, safety of ozanimod for UC

Pregnant women with type 1 diabetes likely to have gut inflammation

Pregnant women with type 1 diabetes likely to have gut inflammation

Could bariatric surgery prevent severe COVID-19?

Could bariatric surgery prevent severe COVID-19?

Low FODMAP diet promising in management of persistent symptoms in coeliac disease

Low FODMAP diet promising in management of persistent symptoms in coeliac disease

Mirikizumab improves disease, symptom severity in patients with Crohn’s disease

Mirikizumab improves disease, symptom severity in patients with Crohn’s disease

Investigative drug for ulcerative colitis passes muster in early trial

Investigative drug for ulcerative colitis passes muster in early trial

Consider AZA discontinuation in kids with sustained, deep remission of Crohn’s disease

Consider AZA discontinuation in kids with sustained, deep remission of Crohn’s disease

Resection, haemodialysis in colon cancer patients tied to higher postoperative complication risk

Resection, haemodialysis in colon cancer patients tied to higher postoperative complication risk

Nasal feeding tubes tied to fewer adverse events than feeding via ostomy

Nasal feeding tubes tied to fewer adverse events than feeding via ostomy

Inpatient, ED use of faecal immunochemical testing mostly incorrect: study

Inpatient, ED use of faecal immunochemical testing mostly incorrect: study